David Bonita serves as a General Partner at OrbiMed, focusing on healthcare private equity. He leverages his dual MD/MBA from Columbia University to guide investments in biopharmaceuticals and medical devices, serving on the boards of several public and private companies like Acutus Medical and Prelude Therapeutics.
Topics They Care About
Healthcare Investing
As a General Partner at OrbiMed, he has a long and successful track record of investing in innovative healthcare companies across various stages of development.
Medical Devices
Serves on the boards of multiple medical technology companies, including Acutus Medical, and has led numerous investments in the device and diagnostics sectors.
Venture Lifecycle
He guides companies from inception to successful exit, demonstrating expertise across the entire investment cycle, as seen with his involvement in Bolt Medical.
Media Appearances
OrbiMed Announces New General Partner. Featured in Business Wire